Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / fto-ip-risk-assessment-summary.docx
fto-ip-risk-assessment-summary.docx
Parties
HARKNESS LLP
Solstice Biomedical Devices Ltd
Solstice Biomedical Inc
NovaSense Medical Technologies Inc
Crestline IP Advisory LLC
Pinnacle Regulatory Consulting Group LLC
Asset Management Patent Group LLP
Meridian Conformity Assessment GmbH
Dates
April 24, 2025
April 10, 2025
February 14, 2025
February 10, 2025
September 12, 2024
November 14, 2019
June 18, 2022
March 7, 2024
April 22, 2025
March 3, 2025
Amounts
$1.24
$215,000
$25
$50
Obligations
Any design modifications to the electrode coating architecture must be carefully evaluated for their impact on several critical parameters: • Analytical Performance
Any modification to the electrode coating must maintain or improve this performance level
The Pre-Submission (Pre-Sub) meeting package and the subsequent 510(k) submission must accurately describe the commercial embodiment of the Lumina C14 sensor, including its electrode coating architecture
If design modifications are adopted, the device description in these regulatory submissions must reflect the modified design
However, the FTO analysis has practical implications for the regulatory timeline and submission strategy that must be carefully managed: Pre-Sub Meeting Package Alignment
Timeliness is critical, as the design-around assessment must be completed in advance of the Pre-Sub package submission target date